A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn
Public ClinicalTrials.gov record NCT00627016. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Multicenter, Randomized, Double-Blind, Parallel Group, Placebo Controlled Trial to Evaluate the Efficacy of TAK-390MR (30 mg QD) Compared to Placebo on Relief of Nocturnal Heartburn in Subjects With Symptomatic Gastroesophageal Reflux Disease (GERD)
Study identification
- NCT ID
- NCT00627016
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Takeda
- Industry
- Enrollment
- 305 participants
Conditions and interventions
Conditions
Interventions
- Dexlansoprazole Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2008
- Primary completion
- Feb 28, 2009
- Completion
- Feb 28, 2009
- Last update posted
- Apr 27, 2011
2008 – 2009
United States locations
- U.S. sites
- 43
- U.S. states
- 22
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Tucson | Arizona | — | — |
| Not listed | Anaheim | California | — | — |
| Not listed | Garden Grove | California | — | — |
| Not listed | Lancaster | California | — | — |
| Not listed | Oakland | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Sherwood | California | — | — |
| Not listed | Westlake Village | California | — | — |
| Not listed | Jupiter | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | New Smyrna Beach | Florida | — | — |
| Not listed | Ocala | Florida | — | — |
| Not listed | St. Petersburg | Florida | — | — |
| Not listed | Zephyrhills | Florida | — | — |
| Not listed | Moline | Illinois | — | — |
| Not listed | Clive | Iowa | — | — |
| Not listed | Wichita | Kansas | — | — |
| Not listed | Metairie | Louisiana | — | — |
| Not listed | Prince Frederick | Maryland | — | — |
| Not listed | Jefferson City | Missouri | — | — |
| Not listed | Egg Harbor Town | New Jersey | — | — |
| Not listed | Great Neck | New York | — | — |
| Not listed | Greensboro | North Carolina | — | — |
| Not listed | Harrisburg | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Mogadore | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Duncansville | Pennsylvania | — | — |
| Not listed | Bristol | Tennessee | — | — |
| Not listed | Chattanooga | Tennessee | — | — |
| Not listed | Johnson City | Tennessee | — | — |
| Not listed | Kingsport | Tennessee | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | El Paso | Texas | — | — |
| Not listed | Fort Worth | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Odessa | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Ogden | Utah | — | — |
| Not listed | Norfolk | Virginia | — | — |
| Not listed | Spokane | Washington | — | — |
| Not listed | Monroe | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00627016, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 27, 2011 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00627016 live on ClinicalTrials.gov.